451 related articles for article (PubMed ID: 21778422)
1. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
[TBL] [Abstract][Full Text] [Related]
2. Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice.
Sberna AL; Assem M; Gautier T; Grober J; Guiu B; Jeannin A; Pais de Barros JP; Athias A; Lagrost L; Masson D
J Hepatol; 2011 Jul; 55(1):154-61. PubMed ID: 21145854
[TBL] [Abstract][Full Text] [Related]
3. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
Park JG; Xu X; Cho S; Lee AH
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
5. Inducible ApoE gene repair in hypomorphic ApoE mice deficient in the low-density lipoprotein receptor promotes atheroma stabilization with a human-like lipoprotein profile.
Eberlé D; Luk FS; Kim RY; Olivas VR; Kumar N; Posada JM; Li K; Gaudreault N; Rapp JH; Raffai RL
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1759-67. PubMed ID: 23788760
[TBL] [Abstract][Full Text] [Related]
6. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
7. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
8. Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development.
Pan S; White TA; Witt TA; Chiriac A; Mueske CS; Simari RD
Circ Res; 2009 Sep; 105(7):713-20, 8 p following 720. PubMed ID: 19713537
[TBL] [Abstract][Full Text] [Related]
9. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
10. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
[TBL] [Abstract][Full Text] [Related]
12. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.
Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1745-52. PubMed ID: 18617647
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
[TBL] [Abstract][Full Text] [Related]
14. Dietary supplementation with long-chain monounsaturated fatty acid isomers decreases atherosclerosis and alters lipoprotein proteomes in LDLr
Yang ZH; Gordon SM; Sviridov D; Wang S; Danner RL; Pryor M; Vaisman B; Shichijo Y; Doisaki N; Remaley AT
Atherosclerosis; 2017 Jul; 262():31-38. PubMed ID: 28486149
[TBL] [Abstract][Full Text] [Related]
15. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
[TBL] [Abstract][Full Text] [Related]
17. Hepatic NPC1L1 promotes hyperlipidemia in LDL receptor deficient mice.
Wang Y; Tang W; Yang P; Shin H; Li Q
Biochem Biophys Res Commun; 2018 May; 499(3):626-633. PubMed ID: 29601818
[TBL] [Abstract][Full Text] [Related]
18. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
[TBL] [Abstract][Full Text] [Related]
19. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
[TBL] [Abstract][Full Text] [Related]
20. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice.
Hartman HB; Gardell SJ; Petucci CJ; Wang S; Krueger JA; Evans MJ
J Lipid Res; 2009 Jun; 50(6):1090-100. PubMed ID: 19174369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]